Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IRENE Study: Phase 2 Study of INCMGA00012 and the Oncolytic Virus Pelareorep in Metastatic Triple Negative Breast Cancer

NCT04445844 is registered in ClinicalTrials.gov with Mridula George, MD as lead sponsor.

NCT NCT04445844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04445844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IRENE Study: Phase 2 Study of INCMGA00012 and the Oncolytic Virus Pelareorep in Metastatic Triple Negative Breast Cancer
Lead sponsor
Mridula George, MD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 13, 2020
Completion date
June 30, 2025
Enrollment
25 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, locally advanced breast carcinoma, metastatic triple-negative breast carcinoma, prognostic stage iv breast cancer ajcc v8, triple-negative breast cancer